can tirzepatide cause joint pain and Back Pain: Understanding the Connection Tirzepatide body aches: why they

Orforglipron vs Farxiga: A New Chapter in Oral Diabetes Therapy Big news from the diabetes frontEli Lillys oral GLP-1 candidate Orforglipron just outperformed Farxiga (dapagliflozin) in two Phase III trials

Lilly will be launching small molecule orforglipron in late 2026 following an FDA PDUFA date in April, having built over $1bn in inventory as it anticipates high demand

This guide compares these programs to help you make an informed decision based on your individual needs and preferences

If you have ever explored modern, medically guided weight loss options, there is a good chance you have come across semaglutide and probably found yourself asking []

The pharmaceutical manufacturers of semaglutide and tirzepatide initiated litigation to stop the production of compounded versions of these medications, and those lawsuits were recently dismissed